CD47 and neoplasm: Furthermore, in colorectal cancer, when anti-CD47 and anti-PD-1 combination therapy is administered in addition to radiation therapy (RT), there was a further decrease in tumor volume and increase in percent survival, in both the irradiated and abscopal tumors [84].